PRESS RELEASE published on 04/25/2023 at 15:06, 2 years 7 months ago Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 04/21/2023 at 07:39, 2 years 7 months ago EQS-Adhoc: ad pepper media International N.V.:
PRESS RELEASE published on 04/20/2023 at 14:15, 2 years 7 months ago ad pepper media International N.V.: Webgains launches new AI-powered publisher platform – smarter connections & more profit
PRESS RELEASE published on 02/07/2023 at 14:36, 2 years 9 months ago Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 02/06/2023 at 14:55, 2 years 9 months ago EQS-Adhoc: ad pepper media International N.V. reports strong final quarter
PRESS RELEASE published on 01/12/2023 at 13:44, 2 years 10 months ago ad pepper media International N.V.: Webgains launches AI and ML Power Suite
Published on 12/05/2025 at 02:35, 4 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 28 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 13 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
